Skip to content
Screener

Globus Medical GMED Allowance for Doubtful Accounts Receivable (Current)

Allowance for Doubtful Accounts Receivable (Current) at other companies

IAR
Integra LifeSciencesIART
$7.33M+6.9%
Xtant Medical Holdings logo
Xtant Medical HoldingsXTNT
$2.23M+24.5%
SI-BONE, Inc. logo
SI-BONE, Inc.SIBN
$1.06M+79.7%
Bioventus logo
BioventusBVS
$2.61M-9.9%
OrthoPediatrics logo
OrthoPediatricsKIDS
$1.68M+19.1%
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$789.6M+5.9%
Gross profit$548.2M+10.4%
Operating income$182.4M+140%
Net income$151.6M-25.3%
EPS (diluted)$1.10-26.2%

Balance sheet

See full
Cash & equivalents$507.7M+121%
Total debt$112.3M-7.6%
Total equity$4.8B+11.0%
Total assets$5.5B+10.6%

Cash flow

See full
Operating cash flow$209.7M+169%
CapEx$33.2M-28.8%
Free cash flow$176.6M+464%

Valuation

See full
Market cap$11.57B+44.1%
Enterprise value$11.17B+41.1%
P/E21.6×-0.9×
P/S3.7×+0.6×

Profitability

See full
Gross margin68.5%+5.8pp
Operating margin20.3%+9.6pp
Net margin17%+3.4pp
FCF margin24%+3.9pp

Returns & leverage

See full
Return on equity11.8%+3.2pp
Debt / equity0.0×
Current ratio4.6×+0.5×

Where this comes from

Reported directly by Globus Medical in its filing.

Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent.

The source filing: Globus Medical’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 5:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054450
(In thousands, except share and per share values)June 30, 2026December 31, 2025
Current assets:
Cash and cash equivalents$507,745$526,156
Short-term marketable securities87,39731,087
Accounts receivable, net of allowances of $44,371 and $33,434, respectively692,176678,938
Inventories810,897759,277
Prepaid expenses and other current assets70,19565,426
Income taxes receivable47,10264,727
Total current assets2,215,5122,125,611

Item 1. Financial Statements

FAQ

What is Globus Medical's allowance for doubtful accounts receivable (current)?
Globus Medical (GMED) reported allowance for doubtful accounts receivable (current) of $44.37M in Q2 2026.
How has Globus Medical's allowance for doubtful accounts receivable (current) changed year-over-year?
Globus Medical's allowance for doubtful accounts receivable (current) increased by 66.8% year-over-year, from $26.61M to $44.37M.
What is the long-term trend for Globus Medical's allowance for doubtful accounts receivable (current)?
Over 5 years (2020 to 2025), Globus Medical's allowance for doubtful accounts receivable (current) has grown at a 50.0% compound annual growth rate (CAGR), from $4.41M to $33.43M.
What does allowance for doubtful accounts receivable (current) mean?
This is the valuation allowance for current receivables that are considered uncollectible due to disputes, bankruptcy, or other non-payment issues. It serves as a buffer against potential losses from customer defaults. It is a critical indicator of the health of the company's accounts receivable portfolio.

Ask your AI about Globus Medical's allowance for doubtful accounts receivable (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude